Circadian variation in plasma homovanillic acid level during and after alcohol withdrawal in alcoholic patients

scientific article

Circadian variation in plasma homovanillic acid level during and after alcohol withdrawal in alcoholic patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1530-0277.1992.TB00697.X
P698PubMed publication ID1335220

P2093author name stringSuzuki Y
Sano H
Yokoyama T
Ohara K
Ishigaki T
Yazaki R
P2860cites workInfluence of dopamine agonists on plasma and brain levels of homovanillic acidQ48933087
A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controlsQ48957224
The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditionsQ48960763
Estimation of human blood plasma 5-hydroxyindoleacetic acid and homovanillic acidQ33260241
The treatment of alcohol withdrawalQ38669841
NIH conference. Alcohol withdrawal and noradrenergic functionQ39159254
Changes in monoamine concentrations in mouse brain associated with ethanol dependence and withdrawalQ41874766
3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: Possible indicators of central dopaminergic activityQ43513468
Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatmentQ44853637
A comparison of the effects of chronic administration of ethanol and acetaldehyde to mice: evidence for a role of acetaldehyde in ethanol dependenceQ48569590
Acute and chronic effects of neuroleptic drugs on plasma and brain homovanilic acid in the ratQ48630734
Circadian changes in homovanillic acid and ascorbate levels in the rat striatum using microprocessor-controlled voltammetryQ48858324
Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophreniaQ48923783
P433issue6
P921main subjectcircadian rhythmQ208353
P304page(s)1047-1051
P577publication date1992-12-01
P1433published inAlcoholism: Clinical and Experimental ResearchQ4713331
P1476titleCircadian variation in plasma homovanillic acid level during and after alcohol withdrawal in alcoholic patients
P478volume16

Reverse relations

cites work (P2860)
Q44253186A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic function
Q28541316A heuristic model of alcohol dependence
Q35146112Alcohol and withdrawal: from animal research to clinical issues
Q72079719Circadian variation in plasma 5‐hydroxyindoleacetic acid level during and after alcohol withdrawal: phase advances in alcoholic patients compared with normal subjects
Q46776535DBH*444G/A polymorphism of the dopamine-beta-hydroxylase gene is associated with alcoholism but not with severe alcohol withdrawal symptoms.
Q41261444Detection of new human metabolic urinary markers in chronic alcoholism and their reversal by aqueous extract of Tinospora cordifolia stem.
Q71370134Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome
Q36717483Genetic polymorphisms related to delirium tremens: a systematic review
Q44443824Homovanillic acid (HVA) plasma levels inversely correlate with attention deficit-hyperactivity and childhood neglect measures in addicted patients.
Q33945794Impaired sleep during the post-alcohol withdrawal period in alcoholic patients
Q41159382Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991.
Q44437032Plasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene.
Q44224065Risk for delirium tremens in patients with alcohol withdrawal syndrome
Q52994373β-Carbolines in alcohol-dependent intensive care patients during prophylactics and therapy of alcohol withdrawal syndrome.